FDA Drug Safety Newsletter
The Food and Drug Administration has released the first issue of its new Drug Safety Newsletter. This quarterly online publication provides information for health care professionals about the findings of selected postmarketing drug safety reviews from the Center for Drug Evaluation and Research. It also has information on recently approved new molecular entities. To download the inaugural issue of the newsletter or a fact sheet, visit
www.fda.gov/cder/dsn/default.htm
Hotline Expands Medicare Advice
The Medicare Rights Center's Professional Hotline has expanded its service to include guidance and advice on Medicare benefits, rights, and options to professionals working with older adults and people with disabilities who are on Medicare. Until now, the hotline has focused on guidance for Medicare prescription drug benefits through private drug plans. The service is available free, Monday through Friday, from 10:00 a.m. to 6:00 p.m. EST, at 877-794-3570.